Luye Pharma Group's market cap is currently $8.76B. The company's EPS TTM is HK$0.221; its P/E ratio is 10.79; Luye Pharma Group is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is HK$0.12. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	¥ 6.14B	¥ 5.98B	¥ 5.20B	¥ 5.54B	¥ 6.36B
Gross Profit	¥ 4.20B	¥ 4.14B	¥ 3.40B	¥ 3.99B	¥ 4.88B
Operating Income	¥ 887.44M	¥ 1.21B	¥ 386.99M	¥ 1.42B	¥ 1.99B
EBITDA	¥ 2.08B	¥ 1.81B	¥ 906.88M	¥ 1.88B	¥ 2.39B
Net Income	¥ 532.61M	¥ 604.81M	¥ -144.78M	¥ 706.59M	¥ 1.47B
Balance Sheet
Cash & Short-Term Investments	¥ 6.11B	¥ 5.54B	¥ 5.51B	¥ 5.41B	¥ 5.19B
Total Assets	¥ 25.49B	¥ 24.25B	¥ 22.58B	¥ 20.63B	¥ 19.31B
Total Debt	¥ 8.42B	¥ 9.10B	¥ 9.49B	¥ 9.98B	¥ 8.07B
Net Debt	¥ 5.18B	¥ 6.78B	¥ 7.05B	¥ 6.12B	¥ 5.74B
Total Liabilities	¥ 11.96B	¥ 13.21B	¥ 13.47B	¥ 12.53B	¥ 9.94B
Stockholders' Equity	¥ 12.53B	¥ 10.18B	¥ 8.49B	¥ 7.89B	¥ 9.22B
Cash Flow
Free Cash Flow	¥ 430.23M	¥ 490.14M	¥ -1.36B	¥ -486.43M	¥ -1.48B
Operating Cash Flow	¥ 1.60B	¥ 1.65B	¥ 182.37M	¥ 1.03B	¥ 1.74B
Investing Cash Flow	¥ -1.42B	¥ -1.66B	¥ -3.44B	¥ 138.20M	¥ -2.69B
Financing Cash Flow	¥ 841.60M	¥ 54.15M	¥ 1.88B	¥ 253.98M	¥ 1.61B

Currency in CNY

Luye Pharma Group Earnings and Revenue History

Income Statement >

Luye Pharma Group Debt to Assets

Balance Sheet >

Luye Pharma Group Cash Flow

Cash Flow >

Luye Pharma Group Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing